Israel: Third Subject Enrolled, First and Second Subject Complete 2-Month Follow-Ups

  • Ongoing study
  • Location: Beer Yaakov, Israel
  • Clinical Investigator: Moshe Kotler, M.D.
  • Estimated study budget: $463,000
  • Already raised: $39,000
  • Needed to complete this study: $423,000

On October 30, 2013, the third subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for 12 subjects with chronic, treatment-resistant PTSD. Two-month follow-up evaluations were conducted for the first two subjects on September 17 and October 3. This third subject will enable our third (of three) co-therapist team to start treating subjects. Goals for this study include (1) gathering evidence for the safety and effectiveness of MDMA-assisted psychotherapy for subjects with PTSD mostly related to war and terrorism, (2) comparing the effectiveness of different doses of MDMA for therapy and double-blind, (3) working in direct association with the Israeli Ministry of Health, and (4) exploring the use of MDMA-assisted psychotherapy in other cultural contexts.